Comparison of microbial cellulose to silver based burn dressing intreatment of superficial burns

Microbial cellulose dressing for partial thickness burns compared to treatment with silver sulphadiazine, a prospective randomised clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14797020

Enrollment

Registered

2017-11-06

Start date

2014-10-01

Completion date

Unknown

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

partial thickness burns Injury, Occupational Diseases, Poisoning partial thickness burns

Interventions

The patients are recruited at the trial site. Those who are eligible according to the inclusion criteria were informed about the study, given the opportunity to ask questions to the investigator, and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Thermal injury of any aetiology 2. Superficial or deep partial thickness burn 3. Recent burn (within the first 72 hours) 4. Aged 5 years or more.

Exclusion criteria

Exclusion criteria: 1. Children younger than 5 years 2. Full thickness burn regardless of the percentage of burn 3. Pregnant or breast feeding women

Design outcomes

Primary

Measure	Time frame
Burn wound healing time is measured using the difference between the date of admission and the first date at which the evaluation done by the attending surgeon can verify that the wound is epithelialised at each wound care procedure, the difference between the dates is calculated as number of days at the end of the study.	—

Secondary

Measure	Time frame
1. Rate of infection is measured using the number of patients in each group who showed presence of clinical signs of infection. Evaluation is done and recorded at each wound care procedure, the calculation of rate (the number of patients with signs of infections in one group/total number of patients in that group) is done at the end of the study. 2. Duration of hospital stay is measured using the difference between the date of admission and that of discharge from the hospital. The dates are recorded prospectively and the difference is calculated as number of days at the end of the study. 3. Pain scoring during and after dressing change is measured using the pain assessment scale Face, Legs, Activity, Cry, Consolability (FLACC) at each wound care procedure, and it is recorded prospectively. 4. Number of dressing changes needed is measured using the sum of total number of dressing changes required for each patient during the time between the date of admission and the date of wound healing. Each dressing change is recorded prospectively; the sum is calculated at the end of the study	—

Measure

Time frame

1. Rate of infection is measured using the number of patients in each group who showed presence of clinical signs of infection. Evaluation is done and recorded at each wound care procedure, the calculation of rate (the number of patients with signs of infections in one group/total number of patients in that group) is done at the end of the study. 2. Duration of hospital stay is measured using the difference between the date of admission and that of discharge from the hospital. The dates are recorded prospectively and the difference is calculated as number of days at the end of the study. 3. Pain scoring during and after dressing change is measured using the pain assessment scale Face, Legs, Activity, Cry, Consolability (FLACC) at each wound care procedure, and it is recorded prospectively. 4. Number of dressing changes needed is measured using the sum of total number of dressing changes required for each patient during the time between the date of admission and the date of wound healing. Each dressing change is recorded prospectively; the sum is calculated at the end of the study

—

Countries

Egypt

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026